Image

Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women

Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women

Recruiting
21-65 years
Female
Phase N/A

Powered by AI

Overview

Cervical cancer remains an important public health issue affecting women's health. Cervical cancer screening plays a key role in reducing morbidity and mortality through early detection. Women's decisions to participate in screening are influenced not only by knowledge, but also by psychosocial factors such as social norms, perceived threat, perceived benefits and barriers, and self-efficacy. The Cervical Cancer Screening Uptake Questionnaire (CCSTQ) is a multidimensional instrument designed to assess psychological and social determinants that may influence women's participation in cervical cancer screening. The aim of this study is to translate and culturally adapt the CCSTQ into Turkish and to evaluate its psychometric properties among Turkish women.

Description

Cervical cancer remains an important public health issue affecting women's health. Cervical cancer screening plays a key role in reducing morbidity and mortality through early detection. Women's decisions to participate in screening are influenced not only by knowledge, but also by psychosocial factors such as social norms, perceived threat, perceived benefits and barriers, and self-efficacy. The Cervical Cancer Screening Uptake Questionnaire (CCSTQ) is a multidimensional instrument designed to assess psychological and social determinants that may influence women's participation in cervical cancer screening. The aim of this study is to translate and culturally adapt the CCSTQ into Turkish and to evaluate its psychometric properties among Turkish women.

This is a methodological study designed to translate, culturally adapt, and evaluate the psychometric properties of the CCSTQ in Turkish women. The study will be conducted in two phases: (1) translation and cross-cultural adaptation following international guidelines and recommendations; and (2) psychometric evaluation including factor structure, convergent validity, internal consistency, test-retest reliability, item discrimination, ceiling and floor effects, and known-groups validity. Women aged 21-65 years who meet the eligibility criteria and complete the Turkish version of the CCSTQ for psychometric evaluation. The study will end when the target sample size is reached and final assessments are completed.

Statistical analyses will be conducted using International Business Machines Statistical Package for the Social Sciences (IBM SPSS) Statistics.

  • Continuous variables: mean ± standard deviation (SD) for normally distributed data; median and range for non-normally distributed data
  • Categorical variables: number and percentage
  • Normality assessment: Kolmogorov-Smirnov test and visual methods
  • Exploratory Factor Analysis (EFA) for construct validity
  • Intraclass Correlation Coefficient (ICC) for test-retest reliability
  • Cronbach's alpha coefficient for internal consistency
  • Significance level set at probability value (p) \< 0.05
  • Ceiling and floor effects defined as \>15% concentration at the highest or lowest possible score.

Eligibility

Inclusion Criteria:

  • Native Turkish speakers who can read and understand Turkish
  • Aged between 21 and 65 years
  • Able to communicate consciously and effectively
  • Previously and/or currently sexually active
  • Provide informed consent and agree to complete the Cervical Cancer Screening Uptake Questionnaire (CCSTQ)
  • Voluntary female participants

Exclusion Criteria:

  • History of total hysterectomy without cervical preservation
  • Previous diagnosis of cervical cancer
  • Severe mental illness or cognitive impairment
  • Inability to complete the CCSTQ

Study details
    Healthy
    Cervical Cancer Screening

NCT07451340

Ankara University

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.